Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Public | 2 | 2019 | 48 | 0.620 |
Why?
|
| Safety-net Providers | 1 | 2019 | 89 | 0.550 |
Why?
|
| Health Services Research | 1 | 2019 | 178 | 0.540 |
Why?
|
| Informed Consent | 2 | 2024 | 351 | 0.500 |
Why?
|
| Acquired Immunodeficiency Syndrome | 5 | 1999 | 218 | 0.460 |
Why?
|
| Tuberculosis, Miliary | 1 | 2015 | 10 | 0.450 |
Why?
|
| Tuberculosis, Pleural | 1 | 2015 | 9 | 0.450 |
Why?
|
| PubMed | 1 | 2015 | 21 | 0.440 |
Why?
|
| Antimalarials | 2 | 2012 | 40 | 0.410 |
Why?
|
| Health Status Indicators | 1 | 2014 | 111 | 0.410 |
Why?
|
| Brain Diseases | 3 | 2006 | 298 | 0.360 |
Why?
|
| Emigration and Immigration | 5 | 2007 | 80 | 0.360 |
Why?
|
| Malaria | 1 | 2012 | 93 | 0.350 |
Why?
|
| Disease Outbreaks | 7 | 1996 | 311 | 0.340 |
Why?
|
| Peripheral Nervous System | 1 | 2010 | 44 | 0.320 |
Why?
|
| Public Health | 2 | 2024 | 269 | 0.310 |
Why?
|
| Neurocysticercosis | 2 | 2006 | 27 | 0.300 |
Why?
|
| HIV-1 | 3 | 2010 | 494 | 0.290 |
Why?
|
| Central Nervous System | 1 | 2010 | 269 | 0.280 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 256 | 0.280 |
Why?
|
| HIV Infections | 5 | 2010 | 2046 | 0.280 |
Why?
|
| Antitubercular Agents | 1 | 2010 | 271 | 0.270 |
Why?
|
| Developing Countries | 1 | 2010 | 303 | 0.260 |
Why?
|
| Uncompensated Care | 1 | 2007 | 11 | 0.260 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 392 | 0.240 |
Why?
|
| Tuberculosis | 1 | 2010 | 547 | 0.210 |
Why?
|
| Social Justice | 1 | 2024 | 67 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 903 | 0.200 |
Why?
|
| Malaria, Cerebral | 1 | 2003 | 4 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2007 | 406 | 0.200 |
Why?
|
| Cysticercosis | 2 | 1994 | 21 | 0.200 |
Why?
|
| Sarcoma, Kaposi | 2 | 1998 | 128 | 0.190 |
Why?
|
| Malaria, Falciparum | 1 | 2003 | 58 | 0.190 |
Why?
|
| Personal Autonomy | 1 | 2024 | 209 | 0.190 |
Why?
|
| Humans | 38 | 2024 | 130066 | 0.180 |
Why?
|
| Psychotic Disorders | 1 | 2003 | 146 | 0.180 |
Why?
|
| Relief Work | 1 | 2001 | 29 | 0.170 |
Why?
|
| Housing | 1 | 2001 | 74 | 0.170 |
Why?
|
| Population Surveillance | 4 | 2012 | 393 | 0.170 |
Why?
|
| Orbit | 1 | 2001 | 75 | 0.160 |
Why?
|
| Texas | 9 | 2012 | 3655 | 0.160 |
Why?
|
| Disasters | 1 | 2001 | 101 | 0.160 |
Why?
|
| Craniocerebral Trauma | 1 | 2001 | 143 | 0.150 |
Why?
|
| HIV Seroprevalence | 1 | 1999 | 6 | 0.150 |
Why?
|
| Blood Donors | 1 | 1999 | 58 | 0.150 |
Why?
|
| Utilization Review | 1 | 1999 | 39 | 0.150 |
Why?
|
| Birth Rate | 1 | 2019 | 15 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2001 | 297 | 0.150 |
Why?
|
| Private Sector | 1 | 2019 | 26 | 0.150 |
Why?
|
| Cities | 1 | 2019 | 51 | 0.150 |
Why?
|
| Geography | 1 | 2019 | 114 | 0.150 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 683 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 930 | 0.150 |
Why?
|
| Liver Abscess, Amebic | 1 | 1998 | 3 | 0.140 |
Why?
|
| Community Health Services | 1 | 1999 | 86 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2019 | 759 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2019 | 181 | 0.140 |
Why?
|
| Global Health | 2 | 2014 | 622 | 0.130 |
Why?
|
| Mortality | 1 | 2019 | 263 | 0.130 |
Why?
|
| Data Collection | 1 | 2019 | 370 | 0.130 |
Why?
|
| Pandemics | 1 | 2024 | 1113 | 0.130 |
Why?
|
| Quality of Life | 1 | 2007 | 2072 | 0.130 |
Why?
|
| Internationality | 1 | 1996 | 128 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1374 | 0.120 |
Why?
|
| Topography, Medical | 1 | 2014 | 6 | 0.110 |
Why?
|
| Health Policy | 1 | 1996 | 225 | 0.100 |
Why?
|
| Vibrio Infections | 2 | 1983 | 14 | 0.100 |
Why?
|
| Vibrio | 2 | 1983 | 9 | 0.100 |
Why?
|
| Travel | 2 | 2012 | 117 | 0.100 |
Why?
|
| Cross-Cultural Comparison | 1 | 2013 | 58 | 0.100 |
Why?
|
| Adult | 16 | 2012 | 31012 | 0.100 |
Why?
|
| Europe | 1 | 2014 | 363 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 2015 | 226 | 0.100 |
Why?
|
| Middle Aged | 13 | 2012 | 28314 | 0.100 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 73 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 128 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2013 | 413 | 0.090 |
Why?
|
| United States | 4 | 2019 | 11893 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 154 | 0.090 |
Why?
|
| Male | 19 | 2012 | 64378 | 0.090 |
Why?
|
| Clostridium Infections | 2 | 1988 | 248 | 0.090 |
Why?
|
| Campylobacter jejuni | 1 | 1992 | 6 | 0.090 |
Why?
|
| Campylobacter Infections | 1 | 1992 | 33 | 0.090 |
Why?
|
| Central America | 3 | 2005 | 21 | 0.090 |
Why?
|
| Female | 18 | 2012 | 70239 | 0.080 |
Why?
|
| Seizures | 2 | 1994 | 874 | 0.080 |
Why?
|
| Giardiasis | 1 | 1990 | 11 | 0.080 |
Why?
|
| Child Day Care Centers | 1 | 1990 | 24 | 0.080 |
Why?
|
| Infant | 2 | 2019 | 13266 | 0.080 |
Why?
|
| Honduras | 2 | 2001 | 25 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 439 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 258 | 0.070 |
Why?
|
| Africa | 2 | 1999 | 135 | 0.070 |
Why?
|
| Typhoid Fever | 2 | 1985 | 17 | 0.070 |
Why?
|
| Bacteremia | 1 | 1992 | 433 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2010 | 427 | 0.060 |
Why?
|
| Aged | 7 | 2012 | 20820 | 0.060 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1988 | 91 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2014 | 901 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 5036 | 0.060 |
Why?
|
| Adolescent | 7 | 2012 | 20797 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 550 | 0.050 |
Why?
|
| Mefloquine | 1 | 2003 | 1 | 0.050 |
Why?
|
| Sepsis | 1 | 1988 | 494 | 0.050 |
Why?
|
| Child | 7 | 2012 | 26169 | 0.050 |
Why?
|
| Cholera | 1 | 1983 | 26 | 0.050 |
Why?
|
| Animals | 7 | 2010 | 33641 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 352 | 0.050 |
Why?
|
| Foodborne Diseases | 1 | 1983 | 12 | 0.050 |
Why?
|
| Plasmodium falciparum | 1 | 2003 | 81 | 0.050 |
Why?
|
| Construction Materials | 1 | 2001 | 4 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2007 | 17537 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 1999 | 134 | 0.040 |
Why?
|
| Syndrome | 1 | 2003 | 1157 | 0.040 |
Why?
|
| HIV-2 | 1 | 1999 | 8 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 140 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 947 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2012 | 15002 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 740 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 1999 | 46 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 109 | 0.030 |
Why?
|
| El Salvador | 1 | 1997 | 5 | 0.030 |
Why?
|
| Young Adult | 1 | 2012 | 9981 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1997 | 42 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1999 | 179 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 1997 | 58 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 1997 | 97 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 227 | 0.030 |
Why?
|
| Civil Rights | 1 | 1996 | 10 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 1998 | 227 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1997 | 42 | 0.030 |
Why?
|
| Prejudice | 1 | 1996 | 39 | 0.030 |
Why?
|
| World Health Organization | 1 | 1996 | 116 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 1997 | 70 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 6401 | 0.030 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1996 | 31 | 0.030 |
Why?
|
| Odds Ratio | 1 | 1999 | 1210 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 1997 | 232 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 1996 | 292 | 0.030 |
Why?
|
| Meat | 2 | 1985 | 45 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 1278 | 0.030 |
Why?
|
| Taenia | 1 | 1994 | 4 | 0.030 |
Why?
|
| Praziquantel | 1 | 1994 | 13 | 0.030 |
Why?
|
| Meat Products | 2 | 1984 | 5 | 0.030 |
Why?
|
| Seawater | 2 | 1983 | 12 | 0.030 |
Why?
|
| Food Microbiology | 2 | 1984 | 23 | 0.030 |
Why?
|
| Otitis | 2 | 1983 | 11 | 0.030 |
Why?
|
| Ostreidae | 2 | 1983 | 18 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 87 | 0.020 |
Why?
|
| Risk Factors | 3 | 2005 | 10959 | 0.020 |
Why?
|
| Poultry Products | 1 | 1992 | 2 | 0.020 |
Why?
|
| Turkeys | 1 | 1992 | 3 | 0.020 |
Why?
|
| Los Angeles | 1 | 1992 | 16 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2001 | 3678 | 0.020 |
Why?
|
| Disease Progression | 1 | 1998 | 2192 | 0.020 |
Why?
|
| Diarrhea | 2 | 1983 | 299 | 0.020 |
Why?
|
| Gastroenteritis | 2 | 1983 | 306 | 0.020 |
Why?
|
| USSR | 1 | 1990 | 4 | 0.020 |
Why?
|
| Prevalence | 1 | 1997 | 2687 | 0.020 |
Why?
|
| Homosexuality | 1 | 1990 | 11 | 0.020 |
Why?
|
| Zidovudine | 1 | 1990 | 22 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 33 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 1120 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1990 | 221 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1999 | 3739 | 0.020 |
Why?
|
| Pregnancy | 1 | 1999 | 7389 | 0.020 |
Why?
|
| Neutropenia | 1 | 1988 | 209 | 0.010 |
Why?
|
| Animal Husbandry | 1 | 2005 | 12 | 0.010 |
Why?
|
| Prognosis | 2 | 1992 | 4851 | 0.010 |
Why?
|
| Mexico | 1 | 2005 | 190 | 0.010 |
Why?
|
| Food Contamination | 1 | 1985 | 25 | 0.010 |
Why?
|
| Respirovirus Infections | 1 | 1984 | 19 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1992 | 3349 | 0.010 |
Why?
|
| Botulinum Antitoxin | 1 | 1984 | 1 | 0.010 |
Why?
|
| Botulism | 1 | 1984 | 6 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2005 | 162 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1985 | 150 | 0.010 |
Why?
|
| Clostridium perfringens | 1 | 1983 | 5 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 1873 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1184 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12818 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1984 | 348 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1999 | 98 | 0.010 |
Why?
|
| Hospitals, Municipal | 1 | 1996 | 2 | 0.010 |
Why?
|
| Africa South of the Sahara | 1 | 1997 | 121 | 0.010 |
Why?
|
| Time Factors | 2 | 1984 | 6165 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1996 | 928 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1996 | 1481 | 0.010 |
Why?
|
| Mass Screening | 1 | 1997 | 817 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 3321 | 0.000 |
Why?
|
| Homes for the Aged | 1 | 1984 | 21 | 0.000 |
Why?
|
| California | 1 | 1984 | 127 | 0.000 |
Why?
|
| Salmonella typhi | 1 | 1984 | 19 | 0.000 |
Why?
|
| Nursing Homes | 1 | 1984 | 88 | 0.000 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1984 | 153 | 0.000 |
Why?
|
| Cattle | 1 | 1984 | 500 | 0.000 |
Why?
|
| Feces | 1 | 1984 | 718 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1984 | 1171 | 0.000 |
Why?
|
| Age Factors | 1 | 1984 | 2822 | 0.000 |
Why?
|